United States · Series A startup

Who invested in Goodpath

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

HealthcareWellness

Funding summaryUpdated 5 Nov 2026

$18Mraised across 1 round since 2025, from 1 source

Latest round
Series A, $18MSept 2025
Investors
4
See who backed them

The rounds

  1. Sept 2025

Everyone who backed them

Alumni VenturesVC firm1round
MassMutual VenturesVC firm1round
Healthy VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 5 firms list Goodpath as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

City Light CapitalVC firmPer its own site
B&Y Venture PartnersVC firmPer its own site
Rivas CapitalFamily officePer its own site
Blindspot VenturesVC firmPer its own site
Enable VenturesVC firmPer its own site

Quick answers about Goodpath

Who invested in Goodpath?

Goodpath's investors include Alumni Ventures, Global Founders Capital, MassMutual Ventures and Healthy Ventures.

How much has Goodpath raised?

Goodpath has raised $18M across 1 round since 2025.

When did Goodpath last raise?

Goodpath's most recent round was a Series A of $18M in Sept 2025.

What was Goodpath's biggest round?

Its most recent round, $18M in Sept 2025, is also its largest on record.

Who backed Goodpath first?

Goodpath's first round on record, in Sept 2025, was backed by Alumni Ventures, Global Founders Capital and MassMutual Ventures and 1 others.

What stage is Goodpath at?

Goodpath's latest named round is a Series A, in Sept 2025.

Where is Goodpath based?

Goodpath is based in the United States.

Companies like Goodpath

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.